-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Hims & Hers Health, Raises Price Target to $35

Benzinga·07/23/2026 19:05:54
Listen to the news
Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $28 to $35.